We are live on ! Find out more
SRC

Shufro Rose & Co Portfolio holdings

AUM $1.47B
1-Year Est. Return 19.38%
This Fund
S&P 500
This Quarter Est. Return
+7.08%
1 Year Est. Return
+19.38%
3 Year Est. Return
+47.49%
5 Year Est. Return
+55.37%
10 Year Est. Return
+200.77%
AUM
$1.21B
AUM Growth
+$158M
Cap. Flow
+$11.5M
Cap. Flow %
0.95%
Top 10 Hldgs %
38.56%
Holding
345
New
37
Increased
103
Reduced
110
Closed
29

Sector Composition

Rank Sector Weight
1 Technology 18.58%
2 Healthcare 9.87%
3 Consumer Discretionary 9.58%
4 Financials 8.26%
5 Industrials 4.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IBDS icon
1
iShares iBonds Dec 2027 Term Corporate ETF
IBDS
$3.83B
$122M 10.07%
5,123,260
+5,090,112
+15,356% +$121M
DSTL icon
2
Distillate US Fundamental Stability & Value ETF
DSTL
$1.91B
$49.3M 4.07%
914,423
+315,574
+53% +$16.1M
MSFT icon
3
Microsoft
MSFT
$2.84T
$48.4M 4%
115,083
-9,299
-7% -$3.76M
RSP icon
4
Invesco S&P 500 Equal Weight ETF
RSP
$96.1B
$41.9M 3.46%
247,448
-13,216
-5% -$2.12M
CEF icon
5
Sprott Physical Gold and Silver Trust
CEF
$7.43B
$35.7M 2.94%
1,753,031
+115,195
+7% +$2.19M
LLY icon
6
Eli Lilly
LLY
$1.07T
$35.5M 2.93%
45,584
-5
-0% -$3.56K
TMO icon
7
Thermo Fisher Scientific
TMO
$211B
$35.2M 2.91%
60,615
-601
-1% -$337K
BND icon
8
Vanguard Total Bond Market
BND
$157B
$33.8M 2.79%
464,768
+44,843
+11% +$3.25M
AAPL icon
9
Apple
AAPL
$4.89T
$33.1M 2.73%
192,928
+1,738
+0.9% +$316K
GLW icon
10
Corning
GLW
$126B
$32.4M 2.67%
981,906
+3,430
+0.4% +$109K
IBDR icon
11
iShares iBonds Dec 2026 Term Corporate ETF
IBDR
$3.46B
$32M 2.64%
1,342,440
-1,741,969
-56% -$41.5M
AVY icon
12
Avery Dennison
AVY
$12.3B
$31.6M 2.61%
141,445
-1,029
-0.7% -$213K
BRK.B icon
13
Berkshire Hathaway Class B
BRK.B
$1.07T
$27.1M 2.24%
64,387
+622
+1% +$245K
QCOM icon
14
Qualcomm
QCOM
$176B
$25.9M 2.13%
152,693
+2,099
+1% +$324K
JPM icon
15
JPMorgan Chase
JPM
$939B
$25M 2.06%
124,773
-62,708
-33% -$11.3M
JCI icon
16
Johnson Controls International
JCI
$87.5B
$23.5M 1.94%
360,441
-19,615
-5% -$1.14M
FSK icon
17
FS KKR Capital
FSK
$2.98B
$23.3M 1.92%
1,220,586
+70,161
+6% +$1.39M
TXN icon
18
Texas Instruments
TXN
$255B
$23M 1.9%
132,122
-14,817
-10% -$2.47M
BSCQ icon
19
Invesco BulletShares 2026 Corporate Bond ETF
BSCQ
$3.67B
$21.5M 1.77%
1,118,005
-1,673,038
-60% -$32.2M
SBUX icon
20
Starbucks
SBUX
$118B
$17.5M 1.44%
191,246
+125
+0.1% +$11.6K
MRNA icon
21
Moderna
MRNA
$21.5B
$15.6M 1.29%
+146,584
New +$14.8M
AMZN icon
22
Amazon
AMZN
$2.5T
$14.9M 1.23%
82,712
+1,165
+1% +$194K
OPLN
23
Openlane
OPLN
$4.17B
$13.4M 1.1%
773,164
+18,980
+3% +$285K
INTC icon
24
Intel
INTC
$466B
$13.1M 1.08%
296,218
-16,648
-5% -$742K
GLD icon
25
SPDR Gold Trust
GLD
$131B
$12.9M 1.07%
62,785
-6,154
-9% -$1.18M

Similar funds

Shufro Rose & Co's Q1 2024 Portfolio in Review

As of Q1 2024, Shufro Rose & Co held 345 positions worth $1.21B, up 15% from $1.05B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Shufro Rose & Co's Q1 2024 filing shows 37 new, 103 increased, 110 reduced and 29 closed positions. Its largest new stake was Moderna: 146,584 shares worth $15.6M. The largest sale was iShares iBonds Dec 2026 Term Corporate ETF, an estimated $41.5M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Shufro Rose & Co's largest Q1 2024 buy was Moderna: 146,584 shares worth $15.6M.
  • Shufro Rose & Co added most to iShares iBonds Dec 2027 Term Corporate ETF in Q1 2024, an estimated $121M increase.
  • Shufro Rose & Co's biggest Q1 2024 reduction was iShares iBonds Dec 2026 Term Corporate ETF, cutting an estimated $41.5M.
  • Shufro Rose & Co fully exited Horizon Kinetics Inflation Beneficiaries ETF in Q1 2024, selling an estimated $34.8M.
  • Shufro Rose & Co's ten largest holdings make up 39% of its $1.21B portfolio in Q1 2024.
  • Shufro Rose & Co opened 37 new positions and closed 29 in Q1 2024.
  • Shufro Rose & Co's portfolio value rose 15% quarter-over-quarter to $1.21B.

Based on Shufro Rose & Co's 13F filing for Q1 2024, filed 8 May 2024.